India, which has been battling Corona for a long time, is relieved today. Indeed, following the recommendation of the expert committee, the Drug Controller General of India (DCGI) today approved the vaccine Kovishield of the Serum Institute of India and Kovichen of Bharat Biotech for use in emergency situations in India.
“If there is any doubt about the safety of the vaccine, we will never accept it,” said VG Somani, India’s drug controller general. Vaccines are 110% safe. Some side effects such as mild fever, pain and allergies are common in each vaccine. People may become incomplete with this vaccine, it is complete nonsense.
# Clock I would never approve of anything if there was the slightest problem with security concerns. Vaccines are 110% safe. Some side effects such as mild fever, pain and allergies are common to each vaccine. This (so that people can become impotent) is absolutely rubbish: VG Somani, India’s Drug Controller General pic.twitter.com/ZSQ8hU8gvw
– ANI (@ANI) January 3, 2021
DCGI Director VG Somani said that both vaccines are completely safe and can be used in case of emergency. According to the DCGI, two doses of the vaccine will be given as injections.
These two vaccines can be kept at a temperature of 2 to 8 degrees. It is noteworthy that clinical trials of six corona vaccines are currently underway in India. These include covishield and covacin. The Covishield Astroxy Vaccine, developed by AstraZeneca and the Serum Institute of India, Pune. Kovaxin is a desi vaccine developed in collaboration with the Indian Biotech of Indian Medical Research Council.